Literature DB >> 3597802

Analgesic effect of alprazolam in patients with chronic, organic pain of malignant origin.

F Fernandez, F Adams, V F Holmes.   

Abstract

Effective analgesia is a crucial factor in promoting quality of life for cancer patients. While undergoing treatment with the minor tranquilizer alprazolam for a coincidental psychiatric disturbance, 39 patients with malignancies and an associated causalgic pain syndrome had a marked analgesic response. Diagnostic and treatment guidelines for organic pain syndromes are reviewed, as are indications for the use of anticonvulsants and benzodiazepines as analgesic adjuvants. The results of this study suggest that the use of benzodiazepines for patients with this refractory pain syndrome should be evaluated further.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3597802

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  8 in total

Review 1.  Antidepressants for functional gastrointestinal syndromes.

Authors:  R E Clouse
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

Review 2.  Drug therapy for symptoms associated with anxiety in adult palliative care patients.

Authors:  Susan Salt; Caroline A Mulvaney; Nancy J Preston
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

3.  Evaluation by multidimensional instruments of health-related quality of life of elderly cancer patients undergoing three different "psychosocial" treatment approaches. A randomized clinical trial.

Authors:  G Mantovani; G Astara; B Lampis; A Bianchi; L Curreli; W Orrù; M G Carta; B Carpiniello; P Contu; N Rudas
Journal:  Support Care Cancer       Date:  1996-03       Impact factor: 3.603

4.  Effects of single doses of alprazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.

Authors:  M Linnoila; J M Stapleton; R Lister; H Moss; E Lane; A Granger; M J Eckardt
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 5.  [Drug therapy of anxiety and fear in palliative care patients with cancer or other illnesses : a systematic review].

Authors:  G Nübling; S Allmendinger; S Lorenzl
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

6.  [Pharmacotherapy of cancer pain. 3. Adjuvant drugs.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107

Review 7.  Cancer pain and anxiety.

Authors:  Paul D Thielking
Journal:  Curr Pain Headache Rep       Date:  2003-08

8.  A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea.

Authors:  Ralph J Johnson
Journal:  BMC Psychiatry       Date:  2018-04-03       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.